Short Versus Long Cephalomedullary Nails for Pertrochanteric Hip Fractures: A Randomized Prospective Study

To compare functional and clinical outcomes in patients with pertrochanteric hip fractures treated with either a short (SN) or long (LN) cephalomedullary nail. Prospective, randomized. Clinical investigation was performed at the Mayo Clinic's Level 1 Trauma Center in Rochester, MN. Two hundred...

Full description

Saved in:
Bibliographic Details
Published inJournal of orthopaedic trauma Vol. 33; no. 10; p. 480
Main Authors Shannon, Steven F, Yuan, Brandon J, Cross, 3rd, William W, Barlow, Jonathan D, Torchia, Michael E, Holte, Pamela K, Sems, Stephen A
Format Journal Article
LanguageEnglish
Published United States 01.10.2019
Online AccessGet more information

Cover

Loading…
More Information
Summary:To compare functional and clinical outcomes in patients with pertrochanteric hip fractures treated with either a short (SN) or long (LN) cephalomedullary nail. Prospective, randomized. Clinical investigation was performed at the Mayo Clinic's Level 1 Trauma Center in Rochester, MN. Two hundred twenty patients with intertrochanteric fractures were prospectively randomized to an SN or LN cohort. A total of 168 patients (SN, n = 80; LN, n = 88) had a mean follow-up of 13.9 months. Fifty-two patients did not meet the minimum 3-month follow-up. Demographics were comparable between the cohorts. The primary outcome measurement was functional outcome evaluated by Short Form (SF-36) and Harris Hip scores (HHS) at 3 months. Secondary outcomes included implant failure, peri-implant fracture, mortality, operative time, estimated blood loss, and reoperation. SN and LN cohorts were comparable in all aspects of the SF-36. There was a clinically insignificant difference in the HHS between cohorts. Patients treated in the SN cohort experienced shorter operative times but did not differ in tip-to-apex distance or subtrochanteric fracture extension. There was no difference in implant cutout, deep surgical site infection, or peri-implant fractures. Patients treated with SNs or LNs for pertrochanteric femur fractures experienced comparable functional outcomes as measured by SF-36 and HHS. When compared with the LN cohort, SN patients experienced no difference in peri-implant fracture or lag-screw cutout and tolerated up to 3 cm of subtrochanteric fracture line extension. Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
ISSN:1531-2291
DOI:10.1097/BOT.0000000000001553